These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [THROMBOLYTIC THERAPY OF MYOCARDIAL INFARCT WITH STREPTOKINASE]. HEINRICH HG; COBET H; REX JO Dtsch Gesundheitsw; 1965 Jan; 20():32-6. PubMed ID: 14265021 [No Abstract] [Full Text] [Related]
5. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS]. MATTIOLI G; RABITTI G; NAVA C Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219 [No Abstract] [Full Text] [Related]
6. [THE STATUS OF THE BLOOD FIBRINOLYTIC ACTIVITY IN HEMOPHILIA PATIENTS]. EFENDIEV FA; AKHUNDOVA AM; ABDULLAEV MM; EFENDIEV ZI Klin Med (Mosk); 1963 Jan; 41():122-5. PubMed ID: 14121310 [No Abstract] [Full Text] [Related]
7. [THROMBODENSITOGRAPHY. A METHOD OF DYNAMIC STUDY OF BLOOD COAGULATION]. DINELLI CA; MONTANI E Omnia Med Ther; 1963; 41():123-206. PubMed ID: 14076800 [No Abstract] [Full Text] [Related]
8. The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. FLETCHER AP; SHERRY S; ALKJAERSIG N; SMYRNIOTIS FE; JICK S J Clin Invest; 1959 Jul; 38(7):1111-9. PubMed ID: 13664786 [No Abstract] [Full Text] [Related]
9. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS. LEWIS JH; SHIRAKAWA M Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448 [No Abstract] [Full Text] [Related]
10. [CHANGES IN FIBRINOLYSIS AND BLOOD COAGULATION IN THROMBOLYTIC TREATMENT WITH STREPTOKINASE]. DONNER L; KRCILEK A Cas Lek Cesk; 1965 Jun; 104():641-5. PubMed ID: 14321919 [No Abstract] [Full Text] [Related]
11. [THROMBOLYTIC THERAPY. TRIAL TREATMENT WITH PURIFIED STREPTOKINASE]. MARCHAL G; SOULIE P; BILSKI PASQUIER G; ABASTADO M; CASTEL A; GOGLIN G; PROST RJ; SAMAMA M Arch Mal Coeur Vaiss; 1964 Jul; 57():753-72. PubMed ID: 14182459 [No Abstract] [Full Text] [Related]
12. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY. CLIFFTON EE Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024 [No Abstract] [Full Text] [Related]
13. [TECHNIC FOR THE PREPARATION OF A FIBRINOGEN REAGENT FOR DETERMINATIONS OF FIBRINOLYTIC ACTIVITY]. BLATRIX C; VIGNAL A; STEINBUCH M Hemostase; 1963; 3():179-86. PubMed ID: 14050814 [No Abstract] [Full Text] [Related]
14. EXPERIENCE WITH STREPTOKINASE AS A THROMBOLYTIC AGENT. WINCKELMANN G; HIEMEYER V Scand J Clin Lab Invest; 1964; 16():SUPPL 79:7-14. PubMed ID: 14199708 [No Abstract] [Full Text] [Related]
16. [ON THE MECHANISM OF ACTION OF FIBRINOLYTIC SUBSTANCES]. ROSOLLECK H Thromb Diath Haemorrh; 1963 Jul; 143():459-71. PubMed ID: 14081267 [No Abstract] [Full Text] [Related]
17. [Streptokinase and streptodornase; new fibrinolytic and liquafacient of purulent exudates]. ELIAS COSTA J Dia Med; 1953 Jan; 25(4):73-4. PubMed ID: 13033619 [No Abstract] [Full Text] [Related]
18. [Studies on the effect of urokinase on the fibrinolytic activity of the blood]. ANDREENKO GV; STRUKOVA SM Biokhimiia; 1962; 27():327-9. PubMed ID: 13861411 [No Abstract] [Full Text] [Related]
19. THE VALUE OF STREPTOKINASE-INDUCED FIBRINOLYSIS IN THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION. KOERTGE P; PRAETORIUS E Sangre (Barc); 1964; 17():235-40. PubMed ID: 14218354 [No Abstract] [Full Text] [Related]
20. [Very favorable fibrinolytic action of streptokinase-streptodornase in a case of tuberculous encapsulated pleurisy]. BERNARD E; HERRENSCHMIDT P; SAPIN-JALOUSTRE ; BOIRON M Bull Mem Soc Med Hop Paris; 1951 Jun 1-8; 67(19-20):811-3. PubMed ID: 14859116 [No Abstract] [Full Text] [Related] [Next] [New Search]